Novel Anticoagulants for Venous Thromboembolism

Novel Anticoagulants for Venous Thromboembolism

Novel Anticoagulants for Venous Thromboembolism

Course Director(s): Robert D. McBane, M.D.

Released On: August 13, 2015 - Length: 32:18

Add to Cart




Venous thromboembolism is a major source of morbidity and mortality in our country with more than 300,000 new cases occurring each year. In recent years, a number of variables have been established to improve the rates of VTE in our country: heightened awareness, identification of patients at risk, aggressive VTE prophylaxis campaigns, improved diagnostic methods and treatment strategies.  Despite these accomplishments, the incidence of VTE has not improved and has indeed increased at a rate of 3% annually. Hospital associated VTE accounts for a full 25% of this incidence. Most of the events occur following hospital discharge. This lecture will provide the learner with a concise overview of the VTE prophylaxis with a framework of how to approach VTE prophylaxis in a busy daily hospital practice.    


  • Determine the magnitude of the VTE in hospitalized patients
  • Identify which patients require VTE prophylaxis
  • Define the safety and efficacy of VTE prophylaxis strategies


Robert D. McBane, M.D., FACC

Professor of Medicine
Chair, Section of Vascular Medicine
Mayo Clinic, Rochester, MN


$40 - Streaming Video

$50 - Streaming Video and DVD

Purchase Options

Choose your preferred method


DVD & Online Video

Add to Cart


Online Video Only

Add to Cart

Recently Viewed

Refer a Patient

Arizona: 866-629-6362

Florida: 800-634-1417

Minnesota: 800-533-1564

Back to top